Viamet Pharmaceuticals, Inc.

Release Summary

Viamet Presenting Data Demonstrating Efficacy and Safety of VT-1161 for the Treatment of Recurrent Vulvovaginal Candidiasis at ISIDOG Congress 2017

Viamet Pharmaceuticals, Inc.